Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ishares TrMSCI USA Quality Factor MSCI USA QLT FCT | 301,048 | 337,472 | +36,424 | $51.41M | $60.51M | 26.37% | +$9.10M |
| Invesco Qqq TrUNIT SER 1 | 76,711 | 88,149 | +11,438 | $36.75M | $43.02M | 18.75% | +$6.27M |
| Ishares TrMSCI International Quality MSCI INTL QUALTY | 892,193 | 1,026,290 | +134,097 | $34.84M | $42.58M | 18.56% | +$7.74M |
| Ishares TrEAFE VALUE ETF | 399,186 | 399,186 | 0 | $21.17M | $22.97M | 10.01% | +$1.79M |
| Vanguard Index FdsVALUE ETF | 100,003 | 96,630 | -3,373 | $16.04M | $16.87M | 7.35% | +$827.2K |
| Select Sector Spdr TrSBI CONS STPLS ST STR STAPL ETF | 168,300 | 165,267 | -3,033 | $12.89M | $13.72M | 5.98% | +$828.7K |
| Ishares TrMSCI UK ETF NEW MSCI UK ETF NEW | 216,934 | 209,344 | -7,590 | $7.57M | $7.83M | 3.41% | +$264.9K |
| Ishares IncMSCI Japan ETF MSCI JAPAN ETF | 108,634 | 108,634 | 0 | $7.41M | $7.77M | 3.39% | +$358.5K |
| Select Sector Spdr TrSBI INT UTILS ST STR UTIL ETF | 55,588 | 51,940 | -3,648 | $3.79M | $4.20M | 1.83% | +$407.9K |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 0 | 8,969 | +8,969 | $0 | $999.2K | 0.44% | +$999.2K |
| Bristol-Myers Squibb Company(BMY) | 0 | 17,785 | +17,785 | $0 | $920.2K | 0.40% | +$920.2K |
| Ascendis Pharma A/SADR(ASND) | 0 | 4,585 | +4,585 | $0 | $684.6K | 0.30% | +$684.6K |
| Insmed Incorporated(INSM) | 0 | 7,865 | +7,865 | $0 | $574.1K | 0.25% | +$574.1K |
| Indivior Plc | 0 | 57,293 | +57,293 | $0 | $564.2K | 0.25% | +$564.2K |
| Eli Lilly and Company(LLY) | 0 | 633 | +633 | $0 | $560.8K | 0.24% | +$560.8K |
| argenx SEADR(ARGX) | 0 | 953 | +953 | $0 | $516.6K | 0.23% | +$516.6K |
| Soleno Therapeutics Inc | 0 | 9,706 | +9,706 | $0 | $490.1K | 0.21% | +$490.1K |
| Keros Therapeutics, Inc.(KROS) | 0 | 8,025 | +8,025 | $0 | $466.0K | 0.20% | +$466.0K |
| Nuvalent Inc | 0 | 4,115 | +4,115 | $0 | $421.0K | 0.18% | +$421.0K |
| Janux Therapeutics, Inc.(JANX) | 0 | 7,857 | +7,857 | $0 | $356.9K | 0.16% | +$356.9K |
| Crinetics Pharmaceuticals In | 0 | 6,684 | +6,684 | $0 | $341.6K | 0.15% | +$341.6K |
| Tyra Biosciences, Inc.(TYRA) | 0 | 13,188 | +13,188 | $0 | $310.1K | 0.14% | +$310.1K |
| Apogee Therapeutics Inc | 0 | 5,240 | +5,240 | $0 | $307.8K | 0.13% | +$307.8K |
| Vaxcyte, Inc.(PCVX) | 0 | 2,468 | +2,468 | $0 | $282.0K | 0.12% | +$282.0K |
| Intellia Therapeutics, Inc.(NTLA) | 0 | 13,020 | +13,020 | $0 | $267.6K | 0.12% | +$267.6K |
| Vir Biotechnology, Inc.(VIR) | 0 | 33,650 | +33,650 | $0 | $252.0K | 0.11% | +$252.0K |
| Blueprint Medicines Corp | 0 | 2,618 | +2,618 | $0 | $242.2K | 0.11% | +$242.2K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 4,241 | +4,241 | $0 | $235.6K | 0.10% | +$235.6K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 0 | 19,939 | +19,939 | $0 | $206.6K | 0.09% | +$206.6K |
| Relay Therapeutics, Inc.(RLAY) | 0 | 26,200 | +26,200 | $0 | $185.5K | 0.08% | +$185.5K |
| Zevra Therapeutics, Inc.(ZVRA) | 0 | 21,596 | +21,596 | $0 | $149.9K | 0.07% | +$149.9K |
| Erasca, Inc.(ERAS) | 0 | 46,923 | +46,923 | $0 | $128.1K | 0.06% | +$128.1K |
| Solid Biosciences Inc | 0 | 15,728 | +15,728 | $0 | $109.6K | 0.05% | +$109.6K |
| Vistagen Therapeutics, Inc.(VTGN) | 0 | 34,376 | +34,376 | $0 | $103.5K | 0.05% | +$103.5K |
| Zura Bio LimitedCL A(ZURA) | 0 | 17,495 | +17,495 | $0 | $71.0K | 0.03% | +$71.0K |
| Alector Inc | 0 | 14,708 | +14,708 | $0 | $68.5K | 0.03% | +$68.5K |
| Climb Bio, Inc.(CLYM) | 0 | 12,045 | +12,045 | $0 | $61.3K | 0.03% | +$61.3K |
| Cypherpunk Technologies Inc.(CYPH) | 0 | 18,511 | +18,511 | $0 | $47.6K | 0.02% | +$47.6K |
| Nektar Therapeutics(NKTR) | 0 | 26,107 | +26,107 | $0 | $33.9K | 0.01% | +$33.9K |
| Kezar Life Sciences Inc | 0 | 21,136 | +21,136 | $0 | $16.3K | 0.01% | +$16.3K |